Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1612.00
-61.55 (-3.68%)
< Home < Back

Sun Pharma’s US-based unit recalls 50,680 vials of Testosterone Cypionate Injection

Date: 25-07-2022

Sun Pharmaceutical Industries’ US-based unit is recalling 50,680 vials of Testosterone Cypionate Injection, used to treat low testosterone in adult males, in the American market. The company is recalling the affected lot due to 'water leakage' leading to deviation from current good manufacturing practices (cGMP). The company is also recalling 27 vials of the same medication due to cGMP deviations. The affected lot was produced at Sun Pharma's Halol (Gujarat) based manufacturing plant.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.